Holocene Advisors’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-95,143
Closed -$15.9M 971
2020
Q4
$15.9M Buy
95,143
+33,000
+53% +$5.87M 0.1% 224
2020
Q3
$9.71M Buy
62,143
+6,554
+12% +$1.32M 0.07% 234
2020
Q2
$11.6M Buy
55,589
+15,044
+37% +$3.1M 0.1% 182
2020
Q1
$7.57M Buy
+40,545
New +$9.55M 0.08% 163

Other funds holding TECX

Holocene Advisors's TECX Position: Q1 2021 in Review

Holocene Advisors sold out of Tectonic Therapeutic (TECX) in Q1 2021, closing a stake of 95,143 shares — an estimated $15.9M sold.

Holocene Advisors first reported a position in TECX in Q1 2020 and held it in 4 quarters. The position peaked at $15.9M in Q4 2020. 99 funds tracked by Wall St. Rank hold TECX as of Q1 2021.

  • Holocene Advisors reported no remaining Tectonic Therapeutic position as of Q1 2021 after selling out during the quarter.
  • Holocene Advisors sold 95,143 Tectonic Therapeutic shares in Q1 2021, an estimated $15.9M.
  • Holocene Advisors first reported a position in Tectonic Therapeutic in Q1 2020 and held it in 4 quarters.
  • Holocene Advisors's Tectonic Therapeutic position peaked at $15.9M in Q4 2020.
  • 99 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2021.

Based on Holocene Advisors's 13F filing for Q1 2021, filed 17 May 2021.